Array-comparative genomic hybridization reveals loss of SOCS6 is associated with poor prognosis in primary lung squamous cell carcinoma

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Sriram, Krishna B ^a,b   Larsen, Jill E ^a,c   Francis, Santiyagu M ^a,b   Wright, Casey M ^a   Clarke, Belinda E ^b   Duhig, Edwina E ^b   Brown, Kevin M ^d   Hayward, Nicholas K ^e   Yang, Ian A ^a,b   Bowman, Rayleen V ^a,b   Fong, Kwun M ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b THE PRINCE CHARLES HOSPITAL   (Australia)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^e QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; SOCS6 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE DOSAGE; GENE EXPRESSION REGULATION; GENE LOCATION; GENE LOCUS; GENE LOSS; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; LUNG SQUAMOUS CELL CARCINOMA; MALE; MOLECULAR PATHOLOGY; MUTATOR GENE; OVERALL SURVIVAL; PHENOTYPE; PRIMARY TUMOR; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SOCS6 GENE; TISSUE MICROARRAY; UPREGULATION; CHROMOSOME 18; COPY NUMBER VARIATION; DNA METHYLATION; FOLLOW UP; GENETICS; HUMAN CHROMOSOME; HUMAN GENOME; KAPLAN MEIER METHOD; LUNG TUMOR; METABOLISM; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; RECURRENT DISEASE; REPRODUCIBILITY; SQUAMOUS CELL CARCINOMA; TUMOR CELL CULTURE; TUMOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHROMOSOMES, HUMAN; CHROMOSOMES, HUMAN, PAIR 18; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; DNA METHYLATION; FEMALE; FOLLOW-UP STUDIES; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; GENETIC ASSOCIATION STUDIES; GENOME, HUMAN; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PHENOTYPE; POLYMERASE CHAIN REACTION; PROGNOSIS; RECURRENCE; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TUMOR CELLS, CULTURED;

EID: 84857170380     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030398     Document Type: Article

References (55)

1. Parkin DM, Bray F, Ferlay J, Pisani P, (2005) Global Cancer Statistics, 2002. CA Cancer J Clin 55: 74-108.
2. Hoffman PC, Mauer AM, Vokes EE, (2000) Lung cancer. The Lancet 355: 479-485.
3. Spiro SG, Silvestri GA, (2005) One Hundred Years of Lung Cancer. Am J Respir Crit Care Med 172: 523-529.
4. Scott WJ, Howington J, Feigenberg S, Movsas B, Pisters K, (2007) Treatment of Non-small Cell Lung Cancer Stage I and Stage II. Chest 132: 234S-242S.
5. Balmain A, Gray J, Ponder B, (2003) The genetics and genomics of cancer. Nature Genetics 33: 238-244.
6. Kang JU, Koo SH, Kwon KC, Park JW, Kim JM, (2009) Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lung. BMC Cancer 9: 237.
7. Jonsson G, Staaf J, Vallon-Christersson J, Ringner M, Holm K, et al. (2010) Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics. Breast Cancer Research 12: R42.
8. Carrasco D, Tonon G, Huang Y, Zhang Y, Sinha R, et al. (2006) High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients. Cancer Cell 9: 313-325.
9. Sung JS, Park KH, Kim YH, (2010) Genomic alterations of chromosome region 11p as predictive marker by array comparative genomic hybridization in lung adenocarcinoma patients. Cancer Genetics and Cytogenetics 198: 27-34.
10. Etemadmoghadam D, deFazio A, Beroukhim R, Mermel C, George J, et al. (2009) Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas. Clin Cancer Res 15: 1417-1427.
11. Järvinen A-K, Autio R, Kilpinen S, Saarela M, Leivo I, et al. (2008) High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx. Genes, Chromosomes and Cancer 47: 500-509.
12. Pei J, Balsara B, Li W, Litwin S, Gabrielson E, et al. (2001) Genomic imbalances in human lung adenocarcinomas and squamous cell carcinomas. Genes, Chromosomes and Cancer 31: 282-287.
13. Choi Y-W, Choi JS, Zheng LT, Lim YJ, Yoon HK, et al. (2007) Comparative genomic hybridization array analysis and real time PCR reveals genomic alterations in squamous cell carcinomas of the lung. Lung Cancer 55: 43-51.
14. Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S, et al. (2009) SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet 41: 1238-1242.
15. Weir BA, Woo MS, Getz G, Perner S, Ding L, et al. (2007) Characterizing the cancer genome in lung adenocarcinoma. Nature 450: 893-898.
16. Newnham G, Conron M, McLachlan SA, Dobrovic A, Do H, et al. (2011) Integrated mutation, copy number and expression profiling in resectable non-small cell lung cancer. BMC Cancer 11: 93.
17. Balsara BR, Testa JR, (2002) Chromosomal imbalances in human lung cancer. Oncogene 21: 6877-6883.
18. Boelens MC, Kok K, van der Vlies P, van der Vries G, Sietsma H, et al. (2009) Genomic aberrations in squamous cell lung carcinoma related to lymph node or distant metastasis. Lung Cancer 66: 372-378.
19. Petersen S, Aninat-Meyer M, Schluns K, Gellert K, Dietel M, et al. (2000) Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung. British Journal of Cancer 82: 65-73.
20. Sy SM, Wong N, Lee T-W, Tse G, Mok TS-K, et al. (2004) Distinct patterns of genetic alterations in adenocarcinoma and squamous cell carcinoma. Eur J Cancer 40: 1082-1094.
21. Luk C, Tsao MS, Bayani J, Shepherd F, Squire JA, (2001) Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization. Cancer Genetics and Cytogenetics 125: 87-99.
22. Pei J, Balsara BR, Li W, Litwin S, Gabrielson E, et al. (2001) Genomic imbalances in human lung adenocarcinomas and squamous cell carcinomas. Genes, Chromosomes and Cancer 31: 282-287.
23. Weiss J, Sos ML, Seidel D, Peifer M, Zander T, et al. (2010) Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer. Science Translational Medicine 2: 62ra93.
24. Yan W, Song L, Liang Q, Fang Y, (2005) Progression Analysis of Lung Squamous Cell Carcinomas by Comparative Genomic Hybridization. Tumor Biology 26: 158-164.
25. Larsen JE, Pavey SJ, Passmore LH, Bowman R, Clarke BE, et al. (2007) Expression profiling defines a recurrence signature in lung squamous cell carcinoma. Carcinogenesis 28: 760-766.
26. Miller SA, Dykes DD, Polesky HF, (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215.
27. Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, et al. (2007) Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma. Proceedings of the National Academy of Sciences 104: 20007-20012.
28. Pfaffl M, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
29. Iwakawa R, Kohno T, Kato M, Shiraishi K, Tsuta K, et al. (2011) MYC Amplification as a Prognostic Marker of Early-Stage Lung Adenocarcinoma Identified by Whole Genome Copy Number Analysis. Clinical Cancer Research 17: 1481-1489.
30. Goldstraw P, Ball D, Jett JR, Le Chevalier T, Lim E, et al. (2011) Non-small-cell lung cancer. The Lancet 378: 1727-1740.
31. Chansky K, Sculier J-P, Crowley JJ, Giroux D, Meerbeeck JV, et al. (2009) The International Association for the Study of Lung Cancer Staging Project Prognostic Factors and Pathologic TNM Stage in Surgically Managed Non-small Cell Lung Cancer. Journal of Thoracic Oncology 4: 792-801.
32. Detterbeck FC, Boffa DJ, Tanoue LT, (2009) The New Lung Cancer Staging System. Chest 136: 260-271.
33. Ando T, Ishiguro H, Kimura M, Mitsui A, Mori Y, et al. (2007) Frequent loss of the long arm of chromosome 18 in esophageal squamous cell carcinoma. Oncology Reports 17: 1005-1011.
34. Takebayashi S, Hickson A, Ogawa T, Jung K-Y, Mineta H, et al. (2004) Loss of chromosome arm 18q with tumor progression in head and neck squamous cancer. Genes, Chromosomes and Cancer 41: 145-154.
35. Tanaka T, Watanabe T, Kitayama J, Kanazawa T, Kazama Y, et al. (2009) Chromosome 18q Deletion as a Novel Molecular Predictor for Colorectal Cancer With Simultaneous Hepatic Metastasis. Diagn Mol Pathol 18: 219-225.
36. Lai R-H, Hsiao Y-W, Wang M-J, Lin H-Y, Wu C-W, et al. (2010) SOCS6, down-regulated in gastric cancer, inhibits cell proliferation and colony formation. Cancer Letters 288: 75-85.
37. Larsen L, Ropke C, (2002) Suppressors of cytokine signalling: SOCS. APMIS 110: 833-844.
38. Bayle J, Letard Sb, Frank R, Dubreuil P, De Sepulveda P, (2004) Suppressor of Cytokine Signaling 6 Associates with KIT and Regulates KIT Receptor Signaling. Journal of Biological Chemistry 279: 12249-12259.
39. Krebs DL, Uren RT, Metcalf D, Rakar S, Zhang J-G, et al. (2002) SOCS-6 Binds to Insulin Receptor Substrate 4, and Mice Lacking the SOCS-6 Gene Exhibit Mild Growth Retardation. Mol Cell Biol 22: 4567-4578.
40. Boyd DB, (2003) Insulin and Cancer. Integrative Cancer Therapies 2: 315-329.
41. Hassan HT, (2009) c-Kit expression in human normal and malignant stem cells prognostic and therapeutic implications. Leukemia Research 33: 5-10.
42. Lai R-H, Wang M-J, Yang S-H, Chen J-Y, (2009) Genomic organization and functional characterization of the promoter for the human suppressor of cytokine signaling 6 gene. Gene 448: 64-73.
43. Pollack JR, Sorlie T, Perou CM, Rees CA, Jeffrey SS, et al. (2002) Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proceedings of the National Academy of Sciences of the United States of America 99: 12963-12968.
44. Tan DSP, Lambros MBK, Natrajan R, Reis-Filho JS, (2007) Getting it right: designing microarray (and not 'microawry') comparative genomic hybridization studies for cancer research. Lab Invest 87: 737-754.
45. Boone PM, Bacino CA, Shaw CA, Eng PA, Hixson PM, et al. (2010) Detection of clinically relevant exonic copy-number changes by array CGH. Human Mutation 31: 1326-1342.
46. Przybytkowski E, Ferrario C, Basik M, (2011) The use of ultra-dense array CGH analysis for the discovery of micro-copy number alterations and gene fusions in the cancer genome. BMC Medical Genomics 4: 16.
47. Charchar FJ, Kaiser M, Bingham AJ, Fotinatos N, Ahmady F, et al. (2010) Whole Genome Survey of Copy Number Variation in the Spontaneously Hypertensive Rat. Hypertension 55: 1231-1238.
48. Tommasi S, Mangia A, Iannelli G, Chiarappa P, Rossi E, et al. (2010) Gene copy number variation in male breast cancer by aCGH. Analytical Cellular Pathology 33: 113-119.
49. Ueno T, Tangoku A, Yoshino S, Abe T, Toshimitsu H, et al. (2002) Gain of 5p15 Detected by Comparative Genomic Hybridization as an Independent Marker of Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma. Clinical Cancer Research 8: 526-533.
50. Yamamoto S, Tsuda H, Honda K, Onozato K, Takano M, et al. (2009) Actinin-4 gene amplification in ovarian cancer: a candidate oncogene associated with poor patient prognosis and tumor chemoresistance. Mod Pathol 22: 499-507.
51. Kristensen LS, Hansen LL, (2009) PCR-Based Methods for Detecting Single-Locus DNA Methylation Biomarkers in Cancer Diagnostics, Prognostics, and Response to Treatment. Clin Chem 55: 1471-1483.
52. Kondoa Y, Issa J-PJ, (2010) DNA methylation profiling in cancer. Expert Reviews in Molecular Medicine Vol. 12.
53. Bibikova M, Lin Z, Zhou L, Chudin E, Garcia EW, et al. (2006) High-throughput DNA methylation profiling using universal bead arrays. Genome Research 16: 383-393.
54. Ehrich M, Nelson MR, Stanssens P, Zabeau M, Liloglou T, et al. (2005) Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proceedings of the National Academy of Sciences of the United States of America 102: 15785-15790.
55. Ehrich M, Field JK, Liloglou T, Xinarianos G, Oeth P, et al. (2006) Cytosine Methylation Profiles as a Molecular Marker in Non-Small Cell Lung Cancer. Cancer Research 66: 10911-10918.